Evidence map

ReviewNature reviews. Drug discovery2025

GLP-1-based therapies for diabetes, obesity and beyond.

Daniel J DruckerPubMed ↗Publisher ↗

No numbers read from the abstract.

87 papers cite itlatest 60 shown

2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40281304